Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer

PURPOSE: The interaction of programmed death receptor 1 (PD-1) and its ligand, programmed death receptor ligand 1 (PD-L1), negatively regulates immune responses. This study aimed to clarify PD-L1 expression levels in breast cancer through immunohistochemistry (IHC) and to evaluate associations betwe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Breast Cancer
Autors principals: Bae, Sang Byung, Cho, Hyun Deuk, Oh, Mee-Hye, Lee, Ji-Hye, Jang, Si-Hyong, Hong, Soon Auck, Cho, Junhun, Kim, Sung Yong, Han, Sun Wook, Lee, Jong Eun, Kim, Han Jo, Lee, Hyun Ju
Format: Artigo
Idioma:Inglês
Publicat: Korean Breast Cancer Society 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5053308/
https://ncbi.nlm.nih.gov/pubmed/27721873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2016.19.3.242
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars